CME Group (NASDAQ:CME) Price Target Raised to $310.00 at Deutsche Bank Aktiengesellschaft

CME Group (NASDAQ:CME) had its target price upped by analysts at Deutsche Bank Aktiengesellschaft from $300.00 to $310.00 in a report released on Friday,MarketScreener reports. The brokerage presently has a “buy” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price objective points to a potential upside of 9.65% from the stock’s current price.

A number of other equities research analysts have also recently commented on CME. TD Cowen raised their price target on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a report on Thursday, October 23rd. Argus decreased their price target on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. UBS Group reduced their target price on CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a report on Thursday, October 23rd. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Finally, The Goldman Sachs Group increased their target price on CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research note on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $287.65.

CME Group Trading Down 0.3%

NASDAQ:CME traded down $0.81 during mid-day trading on Friday, hitting $282.73. The company had a trading volume of 1,384,408 shares, compared to its average volume of 2,199,924. The business’s fifty day moving average is $266.87 and its two-hundred day moving average is $272.73. CME Group has a fifty-two week low of $222.56 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $101.95 billion, a P/E ratio of 27.37, a P/E/G ratio of 4.41 and a beta of 0.38.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s revenue was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.68 EPS. As a group, research analysts expect that CME Group will post 10.49 earnings per share for the current year.

Insider Activity at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William R. Shepard bought 262 shares of the stock in a transaction on Thursday, September 25th. The shares were bought at an average cost of $265.19 per share, with a total value of $69,479.78. Following the purchase, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders sold 14,043 shares of company stock valued at $3,791,486 in the last 90 days. 0.30% of the stock is currently owned by corporate insiders.

Institutional Trading of CME Group

A number of large investors have recently modified their holdings of the company. Norges Bank acquired a new stake in shares of CME Group in the 2nd quarter valued at approximately $1,571,447,000. Sanders Capital LLC acquired a new position in CME Group during the third quarter valued at approximately $1,006,932,000. Strive Asset Management LLC bought a new position in shares of CME Group in the third quarter worth about $636,487,000. GQG Partners LLC lifted its holdings in CME Group by 7,676.3% during the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock worth $584,975,000 after buying an additional 2,176,685 shares during the period. Finally, Wellington Management Group LLP increased its holdings in CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock worth $704,068,000 after purchasing an additional 2,089,935 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.